List view / Grid view

Charles Heffern (Product Manager at NanoTemper Technologies)



Expert view: Increasing the efficiency of biologics development: the secret is precise and reliable stability characterisation of candidate molecules

8 September 2020 | By

Biologics are becoming increasingly important for the treatment of a wide variety of diseases, with more biologics receiving regulatory approval from the US Food and Drug Administration (FDA) and European Medicines Agency (EMA) and entering the clinic every year.